Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse (Q45721862)

From Wikidata

Jump to navigation Jump to search

scientific article published in September 2003

Language	Label	Description	Also known as
English	Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse	scientific article published in September 2003

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Cyclosporine A effectively inhibits graft-versus-host disease during development of Epstein-Barr virus-infected human B cell lymphoma in SCID mouse (English)

1 reference

Europe PubMed Central

15 December 2017

Epstein–Barr virus

0 references

1 reference

based on heuristic

inferred from title

author name string

Runliang Gan

1

1 reference

Europe PubMed Central

15 December 2017

Zhihua Yin

2

1 reference

Europe PubMed Central

15 December 2017

Tengfei Liu

3

1 reference

Europe PubMed Central

15 December 2017

Lijiang Wang

4

1 reference

Europe PubMed Central

15 December 2017

Yunlian Tang

5

1 reference

Europe PubMed Central

15 December 2017

Ying Song

6

1 reference

Europe PubMed Central

15 December 2017

publication date

1 September 2003

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

94

1 reference

Europe PubMed Central

15 December 2017

9

1 reference

Europe PubMed Central

15 December 2017

796-801

1 reference

Europe PubMed Central

15 December 2017

Epstein-Barr virus infectious mononucleosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

In nasopharyngeal carcinoma-bearing patients, tumors and lymphocytes are infected by different Epstein-Barr virus strains

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Induction of apoptosis and modulation of activation and effector function in T cells by immunosuppressive drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Baboons undergoing orthotopic concordant cardiac xenotransplantation surviving more than 300 days: effect of immunosuppressive regimen

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

The impact of cyclosporine dose reduction with or without the addition of rapamycin on functional, molecular, and histological markers of chronic allograft nephropathy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Tacrolimus (FK506)-induced mutism after liver transplant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Simultaneous cross-linking of CD6 and CD28 induces cell proliferation in resting T cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Advances in interleukin 2 receptor targeted treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Human acute myeloblastic leukemia-ascites model using the human GM-CSF- and IL-3-releasing transgenic SCID mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Myeloablative intensified conditioning regimen with in vivo T-cell depletion (ATG) followed by allografting in patients with advanced multiple myeloma. A phase I/II study of the German Study-group Multiple Myeloma (DSMM).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Selective depletion of major and minor histocompatibility antigen reactive T cells: towards prevention of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Immunosuppressive drugs in islet xenotransplantation: a tool for gaining further insights in the mechanisms of the rejection process

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

SEQUENTIAL MONITORING OF URINE-SOLUBLE INTERLEUKIN 2 RECEPTOR AND INTERLEUKIN 6 PREDICTS ACUTE REJECTION OF HUMAN RENAL ALLOGRAFTS BEFORE CLINICAL OR LABORATORY SIGNS OF RENAL DYSFUNCTION

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2003.TB01521.X

21 January 2018

Identifiers

10.1111/J.1349-7006.2003.TB01521.X

1 reference

Europe PubMed Central

15 December 2017

1 reference

Europe PubMed Central

15 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45721862&oldid=2077818184"